Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Disease-modifying therapies and features linked to treatment response in type 1 diabetes prevention: A systematic review

Title:	Disease-modifying therapies and features linked to treatment response in type 1 diabetes prevention: A systematic review
Authors:	Felton; JL; Griffin; KJ; Oram; RA; Speake; C; Long; SA; Onengut-Gumuscu; S; Rich; SS; Monaco; GSF; Evans-Molina; DiMeglio; LA; Ismail; HM; Steck; AK; Dabelea; D; Johnson; RK; Urazbayeva; M; Gitelman; Wentworth; JM; Redondo; MJ; Sims; EK; Tobias; DK; Merino; J; Ahmad; A; Aiken; Benham; Bodhini; Clark; AL; Colclough; K; Corcoy; R; Cromer; SJ; Duan; Francis; EC; Gillard; P; Gingras; V; Gaillard; Haider; E; Hughes; Ikle; Jacobsen; LM; Kahkoska; AR; Kettunen; JLT; Kreienkamp; RJ; Lim; L-L; Männistö; JME; Massey; McLennan; N-M; Miller; RG; Morieri; ML; Most; Naylor; RN; Ozkan; B; Patel; KA; Pilla; Prystupa; Raghavan; Rooney; MR; Schön; Semnani-Azad; Z; Sevilla-Gonzalez; Svalastoga; Takele; WW; Tam; CH-t; Thuesen; ACB; Tosur; Wallace; AS; Wang; CC; Wong; JJ; Yamamoto; Young; Amouyal; Andersen; MK; Bonham; MP; Chen; Cheng; F; Chikowore; T; Chivers; SC; Clemmensen; Dawed; AY; Deutsch; AJ; Dickens; LT; Dudenhöffer-Pfeifer; Fernández-Balsells; MM; Fitipaldi; H; Fitzpatrick; SL; SE; Goodarzi; MO; Grieger; JA; Guasch-Ferré; Habibi; N; Hansen; Huang; Harris-Kawano; Hoag; Jones; AG; Koivula; RW; Leong; Leung; GKW; Libman; IM; Liu; Lowe; WL; Morton; Motala; AA; Pankow; JS; Pathirana; Pazmino; Perez; Petrie; JR; Powe; CE; Quinteros; Jain; Ray; Ried-Larsen; Saeed; Santhakumar; Kanbour; Sarkar; Scholtens; DM; Selvin; Sheu; WH-H; Stanislawski; MA; Steenackers; Stefan; Støy; Taylor; Tye; Ukke; GG; Van der Schueren; Vatier; Hannah; W; White; Yu; G; Zhang; Y; Zhou; Beltrand; Polak; Aukrust; I; de Franco; Flanagan; Maloney; McGovern; Molnes; Nakabuye; Njølstad; PR; Pomares-Millan; Provenzano; Saint-Martin; Zhu; Auh; de Souza; Fawcett; Gruber; Mekonnen; EG; Mixter; Sherifali; Eckel; RH; Nolan; Philipson; LH; Brown; Billings; LK; Boyle; Costacou; Dennis; Florez; JC; Gloyn; Gomez; MF; Gottlieb; PA; Greeley; SAW; Hattersley; AT; Hirsch; IB; Hivert; M-F; Hood; KK; Josefson; Kwak; SH; Laffel; Loos; RJF; Ma; RCW; Mathieu; Mathioudakis; Meigs; JB; Misra; Mohan; Murphy; Owen; KR; Ozanne; Pearson; ER; Perng; Pollin; TI; Pop-Busui; Pratley; RE; Redman; Reynolds; RM; Semple; Sherr; Sweeting; Tuomi; Udler; MS; Vesco; Vilsbøll; Wagner; Franks; PW; Ada/Easd
Contributors:	Institute of Molecular and Genomic Medicine
Publisher Information:	SPRINGERNATURE
Publication Year:	2023
Collection:	National Health Research Institutes (NHRI): Institutional Repository / 國家衛生研究院機構典藏
Description:	Type 1 diabetes (T1D) results from immune-mediated destruction of insulin-producing beta cells. Prevention efforts have focused on immune modulation and supporting beta cell health before or around diagnosis; however, heterogeneity in disease progression and therapy response has limited translation to clinical practice, highlighting the need for precision medicine approaches to T1D disease modification.
Document Type:	article in journal/newspaper
File Description:	1860466 bytes; application/pdf
Language:	English
Relation:	Communications Medicine. 2023 Oct 05;3:Article number 130.; http://ir.nhri.org.tw/handle/3990099045/15355; http://ir.nhri.org.tw/bitstream/3990099045/15355/1/NMG2023101310.pdf
DOI:	10.1038/s43856-023-00357-y
Availability:	http://ir.nhri.org.tw/handle/3990099045/15355; https://doi.org/10.1038/s43856-023-00357-y; http://ir.nhri.org.tw/bitstream/3990099045/15355/1/NMG2023101310.pdf
Accession Number:	edsbas.FD095E39
Database:	BASE